Who invested in Envisia Therapeutics?
Envisia Therapeutics's investors include New Enterprise Associates, Canaan, Morningside Group, Pappas Ventures and Wakefield Group.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$46Mraised across 3 rounds since 2013, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $10M sold, first sale Mar 2016
No investor was named in the report.
From a historical funding recordSEC filing: $4.6M sold, first sale Oct 2015
Reported by ca.finance.yahoo.comSEC filing: $15M sold, first sale Nov 2013
From the SEC filings it signed: 2 on the team.
On the board, as filediAdrienne GravesEd MathersGary PhillipsNeal FowlerStephen BlochWilliam Yelle
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Envisia Therapeutics's investors include New Enterprise Associates, Canaan, Morningside Group, Pappas Ventures and Wakefield Group.
Envisia Therapeutics has raised $46M across 3 rounds since 2013.
Envisia Therapeutics's most recent round was a Series A of $17M in Mar 2016.
Envisia Therapeutics's largest round on record is $25M (Series A), in Nov 2013.
Envisia Therapeutics's first round on record, in Nov 2013, was backed by New Enterprise Associates, Canaan and Morningside Group and 2 others.
Envisia Therapeutics's latest named round is a Series A, in Mar 2016.
Envisia Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.